|
| Dipivefrin hydrochloride Basic information |
Product Name: | Dipivefrin hydrochloride | Synonyms: | dipivalylepinephrinehydrochloride;dipivefrinehydrochloride;dipivefrinhydrochloride;hydrochloride,(+-)-este;propanoicacid,2,2-dimethyl-,4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylene;Progate;Propanoic acid,2,2-diMethyl-, 1,1'-[4-[1-hydroxy-2-(MethylaMino)ethyl]-1,2-phenylene] ester,hydrochloride (1:1);DIPIVEFRIN HYDROCHLORIDE (200 MG) | CAS: | 64019-93-8 | MF: | C19H30ClNO5 | MW: | 387.8982 | EINECS: | 264-609-5 | Product Categories: | API | Mol File: | 64019-93-8.mol | |
| Dipivefrin hydrochloride Chemical Properties |
Melting point | 158-159° | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | solubility | Freely soluble in water, very soluble in methanol, freely soluble in ethanol (96 per cent) and in methylene chloride. | pka | 8.40(at 25℃) | form | neat | color | White to Off-White | InChI | InChI=1S/C19H29NO5.ClH/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6;/h8-10,13,20-21H,11H2,1-7H3;1H | InChIKey | VKFAUCPBMAGVRG-UHFFFAOYSA-N | SMILES | C1(OC(=O)C(C)(C)C)=CC(=CC=C1OC(=O)C(C)(C)C)C(O)CNC.Cl |
RIDADR | UN 2811 6.1 / PGIII | HS Code | 2922504500 |
| Dipivefrin hydrochloride Usage And Synthesis |
Description | Dipivefrin hydrochloride is an antiglaucoma prothrombotic drug that is hydrolyzed to its active compound epinephrine by esterases in the cornea. | Chemical Properties | White or almost white, crystalline powder. | Uses | Dipivefrine Hydrochloride acts as an anti-glaucoma agent. | Uses | Adrenergic (ophthalmic) | Definition | ChEBI: The hydrochloride salt of dipivefrin. It is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension. | Brand name | Akpro (Akorn); Propine (Allergan). | in vivo | Dipivefrin hydrochloride (0.3-10 μg/kg; i.p.;) induces enhancement of memory involves central beta- but not alpha-adrenergic mechanisms. |
| Dipivefrin hydrochloride Preparation Products And Raw materials |
|